These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39111739)

  • 1. The Correlation Between Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) and miR-142-3p in Maintenance Hemodialysis Patients With End-Stage Renal Disease.
    Jiang J; Zhou M; Zhang Q; Shen H; Jia Y; Chen Y; Xu X; Jiang H
    Semin Dial; 2024; 37(5):373-379. PubMed ID: 39111739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of circulating coagulation related microRNAs expressions for major adverse cardiac and cerebral event risk in patients undergoing continuous ambulatory peritoneal dialysis: a cohort study.
    Wang Y; Liu C; Wei W; Chen W
    J Nephrol; 2020 Feb; 33(1):157-165. PubMed ID: 31359371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal change in microRNA-130a expression and its correlation with the risk of developing major adverse cardiovascular and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
    Wang H; Xu J; Wu X; Zheng S; Han Y; Ding G
    J Clin Lab Anal; 2021 Dec; 35(12):e24039. PubMed ID: 34708454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.
    Liu D; Zhou S; Mao H
    J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
    Xu L; Hu X; Chen W
    J Nephrol; 2019 Apr; 32(2):307-314. PubMed ID: 30465136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence and potential predictive factors of major adverse cardiac and cerebral events in end-stage renal disease patients on continuous ambulatory peritoneal dialysis: A prospective cohort study.
    Yao C; Zhou L; Huang Q
    Medicine (Baltimore); 2021 Mar; 100(10):e24616. PubMed ID: 33725825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients.
    Chang CH; Fan PC; Lin CY; Yang CH; Chen YT; Chang SW; Yang HY; Jenq CC; Hung CC; Yang CW; Chen YC
    Medicine (Baltimore); 2015 Oct; 94(42):e1836. PubMed ID: 26496326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of hemodialysis quality of care indicators in very elderly patients with end stage kidney disease.
    Kim HW; Jhee JH; Joo YS; Yang KH; Jung JJ; Shin JH; Han SH; Yoo TH; Kang SW; Park JT
    J Nephrol; 2022 Dec; 35(9):2351-2361. PubMed ID: 35666374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Clinical Characterization of Cardiovascularand Cerebrovascular Events in Elderly Hemodialysis Patients.
    Liu W; Wang HZ; Shi Y; Shen W; Dai M
    Iran J Kidney Dis; 2024 Mar; 18(2):124-132. PubMed ID: 38660696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insomnia in patients on incident maintenance dialysis and the risk of major acute cardio-cerebrovascular events and all-cause mortality.
    Kim HW; Heo GY; Kim HJ; Kang SW; Park JT; Lee E
    Nephrol Dial Transplant; 2024 Apr; 39(5):830-837. PubMed ID: 37935519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the hs-CRP/Alb ratio for cardiovascular events in patients with end-stage renal disease undergoing maintenance hemodialysis.
    Luo G; Feng F; Xu H; Li Y; Zou W
    Am J Transl Res; 2024; 16(7):3108-3116. PubMed ID: 39114698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor reflects the lower inflammation, lipid level, and major adverse cardiac and cerebrovascular events risk in maintenance hemodialysis patients.
    Du H; Dai H
    Scand J Clin Lab Invest; 2023 Jul; 83(4):264-270. PubMed ID: 37343271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma microRNA-16-5p and abdominal aortic calcification in maintenance hemodialysis patients.
    Liang Q; Fu C; Liu Y; Liu W; Guo W
    Ren Fail; 2024 Dec; 46(2):2368091. PubMed ID: 39049724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-glucose index as a potential predictor of major adverse cardiovascular and cerebrovascular events in patients with coronary heart disease complicated with depression.
    Zhao W; Wang J; Chen D; Ding W; Hou J; Gui Y; Liu Y; Li R; Liu X; Sun Z; Zhao H
    Front Endocrinol (Lausanne); 2024; 15():1416530. PubMed ID: 39006364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Sensitive Cardiac Troponin T for Prediction of Cardiovascular Outcomes in Stable Maintenance Hemodialysis Patients: A 3-Year Prospective Study.
    Sun L; Wang Y; Zhang N; Xie X; Ding M; Guo H; Li F; Wang X
    Kidney Blood Press Res; 2021; 46(4):484-494. PubMed ID: 34167109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Circulating Proangiogenic MicroRNAs for Predicting Major Adverse Cardiac and Cerebrovascular Events in Unprotected Left Main Coronary Artery Disease Patients Who Underwent Coronary Artery Bypass Grafting.
    Shen J; Chang C; Ma J; Feng Q
    Cardiology; 2021; 146(3):400-408. PubMed ID: 33730720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
    Yao C; Ou J; Zhou L; Liu J
    Scand J Clin Lab Invest; 2023 Apr; 83(2):119-124. PubMed ID: 36847753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of measurement of heart rate variability by holter ECG in hemodialysis patients.
    Kida N; Tsubakihara Y; Kida H; Ageta S; Arai M; Hamada Y; Matsuura N
    BMC Nephrol; 2017 Jan; 18(1):8. PubMed ID: 28056878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic kidney disease in patients undergoing percutaneous or surgical carotid artery revascularization: Insights of the healthcare cost and utilization Project's National Inpatient Sample.
    Lima FV; Yen TY; Butler J; Yang J; Xu J; Gruberg L
    Cardiovasc Revasc Med; 2016 Dec; 17(8):560-565. PubMed ID: 27988086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.